Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...

Tonix Pharmaceuticals Presented Data on TNX-801 Mpox Vaccine at World Vaccine Congress ...

TNX-801 is a live virus vaccine investigational candidate, designed to provide durable protection against mpox and smallpox ...
The Malaysian Reserve

iOncologi Secures Foundational U.S. Patent as Landmark Studies Link COVID19 mRNA Vaccines ...

Findings published in Nature Biomedical Engineering and presented at ESMO 2025 validate iOncologi's Universal Immune ...